Dr VK Paul

The agenda of this event was to examine and assess the opportunities, challenges, and strategic directions of the Indian pharma…

In a communication to Dr V K Paul, Member (health), NITI Aayog, Ministry of External Affairs (MEA) said many issues about vaccines…

Responding to a question at a weekly press conference, Dr V K Paul, Member (health), NITI Aayog, said all decisions on precaution…

The vaccine is being developed by Pune-based Gennova Biopharmaceuticals, informed Dr VK Paul, Member (health), NITI Aayog

So far, about four million shots have been exported

Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15…

The way forward is to watch for its potential presence in the country and take the appropriate public health response, said Dr…

Committee of experts to soon give report on the process of identifying and prioritising patients with co-morbidities, for the…

DCGI’s requirement for more data to grant EUA will not negatively impact the timeline for vaccine roll-out, inform government…

States have been advised to send details of priority population groups by end of October